Estalis and breast cancer in situ Patient Reports February 11, 2012

Estalis Side Effects Report #4517136-7
Estalis side effect was reported by a Physician from on Apr 13, 2004. Female patient, 67 years of age, was treated with Estalis. After drug was administered, patient experienced the following side effects: breast cancer in situ. Estalis dosage: 0.05/0.14 MG/DAY, QW2, TRANSDERMAL. During the same period patient was treated with ASPIRIN, CALCIUM, VITAMIN. Patient recovered.